Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations
© 2022. The Author(s), under exclusive licence to Springer Nature Limited..
The ongoing monkeypox virus (MPXV) outbreak is the largest ever recorded outside of Africa. We isolated and sequenced a virus from the first clinical MPXV case diagnosed in France (May 2022). We report that tecovirimat (ST-246), a US Food and Drug Administration approved drug, is efficacious against this isolate in vitro at nanomolar concentrations, whereas cidofovir is only effective at micromolar concentrations. Our results support the use of tecovirimat in ongoing human clinical trials.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
|---|---|
| Enthalten in: |
Nature microbiology - 7(2022), 12 vom: 21. Dez., Seite 1951-1955 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Frenois-Veyrat, Gaëlle [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Benzamides |
|---|
| Anmerkungen: |
Date Completed 02.12.2022 Date Revised 30.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41564-022-01269-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM348584032 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM348584032 | ||
| 003 | DE-627 | ||
| 005 | 20240331000544.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41564-022-01269-8 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1357.xml |
| 035 | |a (DE-627)NLM348584032 | ||
| 035 | |a (NLM)36344621 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Frenois-Veyrat, Gaëlle |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.12.2022 | ||
| 500 | |a Date Revised 30.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022. The Author(s), under exclusive licence to Springer Nature Limited. | ||
| 520 | |a The ongoing monkeypox virus (MPXV) outbreak is the largest ever recorded outside of Africa. We isolated and sequenced a virus from the first clinical MPXV case diagnosed in France (May 2022). We report that tecovirimat (ST-246), a US Food and Drug Administration approved drug, is efficacious against this isolate in vitro at nanomolar concentrations, whereas cidofovir is only effective at micromolar concentrations. Our results support the use of tecovirimat in ongoing human clinical trials | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a tecovirimat |2 NLM | |
| 650 | 7 | |a F925RR824R |2 NLM | |
| 650 | 7 | |a Isoindoles |2 NLM | |
| 650 | 7 | |a Benzamides |2 NLM | |
| 700 | 1 | |a Gallardo, Franck |e verfasserin |4 aut | |
| 700 | 1 | |a Gorgé, Olivier |e verfasserin |4 aut | |
| 700 | 1 | |a Marcheteau, Elie |e verfasserin |4 aut | |
| 700 | 1 | |a Ferraris, Olivier |e verfasserin |4 aut | |
| 700 | 1 | |a Baidaliuk, Artem |e verfasserin |4 aut | |
| 700 | 1 | |a Favier, Anne-Laure |e verfasserin |4 aut | |
| 700 | 1 | |a Enfroy, Cécile |e verfasserin |4 aut | |
| 700 | 1 | |a Holy, Xavier |e verfasserin |4 aut | |
| 700 | 1 | |a Lourenco, Jérémy |e verfasserin |4 aut | |
| 700 | 1 | |a Khoury, Rhéa |e verfasserin |4 aut | |
| 700 | 1 | |a Nolent, Flora |e verfasserin |4 aut | |
| 700 | 1 | |a Grosenbach, Douglas W |e verfasserin |4 aut | |
| 700 | 1 | |a Hruby, Dennis E |e verfasserin |4 aut | |
| 700 | 1 | |a Ferrier, Audrey |e verfasserin |4 aut | |
| 700 | 1 | |a Iseni, Frédéric |e verfasserin |4 aut | |
| 700 | 1 | |a Simon-Loriere, Etienne |e verfasserin |4 aut | |
| 700 | 1 | |a Tournier, Jean-Nicolas |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nature microbiology |d 2016 |g 7(2022), 12 vom: 21. Dez., Seite 1951-1955 |w (DE-627)NLM257483241 |x 2058-5276 |7 nnns |
| 773 | 1 | 8 | |g volume:7 |g year:2022 |g number:12 |g day:21 |g month:12 |g pages:1951-1955 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41564-022-01269-8 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 7 |j 2022 |e 12 |b 21 |c 12 |h 1951-1955 | ||